Safety and Immunogenicity of a rAd35-EnvA Prototype HIV-1 Vaccine in Combination with rAd5-EnvA in Healthy Adults (VRC 012)

BACKGROUND: VRC 012 was a Phase I study of a prototype recombinant adenoviral-vector serotype-35 (rAd35) HIV vaccine, the precursor to two recently published clinical trials, HVTN 077 and 083. On the basis of prior evaluation of multiclade rAd5 HIV vaccines, Envelope A (EnvA) was selected as the sta...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:PLoS One
Autores principales: Crank, Michelle C., Wilson, Eleanor M. P., Novik, Laura, Enama, Mary E., Hendel, Cynthia S., Gu, Wenjuan, Nason, Martha C., Bailer, Robert T., Nabel, Gary J., McDermott, Adrian B., Mascola, John R., Koup, Richard A., Ledgerwood, Julie E., Graham, Barney S.
Formato: Artigo
Lenguaje:Inglês
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5112788/
https://ncbi.nlm.nih.gov/pubmed/27846256
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0166393
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares